{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T14:10:09Z","timestamp":1791382209146,"version":"4.3.3"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1097\/mao.0b013e3182009665","type":"journal-article","created":{"date-parts":[[2010,12,14]],"date-time":"2010-12-14T08:50:33Z","timestamp":1292316633000},"page":"163-170","source":"Crossref","is-referenced-by-count":20,"title":["Potential Role of Imatinib Mesylate (Gleevec, STI-571) in the Treatment of Vestibular Schwannoma"],"prefix":"10.1097","volume":"32","author":[{"given":"Xabier","family":"Altuna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay Patrick","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael Andrew","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Jesus","family":"Arandazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey P.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Wang-Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Dobrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joni K.","family":"Doherty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weg M.","family":"Ongkeko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-29-20210212","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/00005537-199604000-00012","article-title":"Epidermal growth factor receptor expression by acoustic neuromas.","volume":"106","author":"Sturgis","year":"1996","journal-title":"Laryngoscope"},{"key":"R3-29-20210212","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0165-4608(82)90063-2","article-title":"Cytological and cytogenetical studies on human meningioma.","volume":"6","author":"Zang","year":"1982","journal-title":"Cancer Genet Cytogenet"},{"key":"R4-29-20210212","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/0092-8674(93)90406-G","article-title":"A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor.","volume":"72","author":"Trofatter","year":"1993","journal-title":"Cell"},{"key":"R5-29-20210212","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/363515a0","article-title":"Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2.","volume":"363","author":"Rouleau","year":"1993","journal-title":"Nature"},{"key":"R6-29-20210212","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/322644a0","article-title":"Loss of genes on chromosome 22 in tumorigenesis of human acoustic neuroma.","volume":"322","author":"Seizinger","year":"1986","journal-title":"Nature"},{"key":"R7-29-20210212","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/(SICI)1098-2264(199609)17:1<45::AID-GCC7>3.0.CO;2-2","article-title":"Frequency and distribution of NF2 mutations in schwannomas.","volume":"17","author":"Jacoby","year":"1996","journal-title":"Genes Chromosomes Cancer"},{"key":"R8-29-20210212","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1073\/pnas.92.5.1431","article-title":"Axon-induced mitogenesis of human Schwann cells involves heregulin and p185erbB2.","volume":"92","author":"Morrissey","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R9-29-20210212","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1523\/JNEUROSCI.17-05-01642.1997","article-title":"Expression of neuregulins and their putative receptors, ErbB2 and ErbB3, is induced during Wallerian degeneration.","volume":"17","author":"Carroll","year":"1997","journal-title":"J Neurosci"},{"key":"R10-29-20210212","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/glia.20316","article-title":"Constitutive neuregulin-1\/ErbB signaling contributes to human vestibular schwannoma proliferation.","volume":"53","author":"Hansen","year":"2006","journal-title":"Glia"},{"key":"R11-29-20210212","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1023\/A:1022514105129","article-title":"Myelin basic protein and myelin basic protein peptides induce the proliferation of Schwann cells via ganglioside GM1 and the FGF receptor.","volume":"24","author":"Tzeng","year":"1999","journal-title":"Neurochem Res"},{"key":"R12-29-20210212","first-page":"294","article-title":"Proliferating cell nuclear antigen in the determination of growth rates in acoustic neuromas.","volume":"15","author":"Wiet","year":"1994","journal-title":"Am J Otol"},{"key":"R13-29-20210212","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3109\/00016489109130448","article-title":"Ultrastructural localization of nerve growth factor receptor in acoustic neurinoma.","volume":"487","author":"Matsunaga","year":"1991","journal-title":"Acta Otolaryngol Suppl"},{"key":"R14-29-20210212","first-page":"65","article-title":"Transforming growth factor-beta1 expression in human acoustic neuroma.","volume":"20","author":"Cardillo","year":"1999","journal-title":"Am J Otol"},{"key":"R15-29-20210212","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1097\/00129492-200409000-00024","article-title":"Correlation of growth factor receptor expression with clinical growth in vestibular schwannomas.","volume":"25","author":"O'Reilly","year":"2004","journal-title":"Otol Neurotol"},{"key":"R16-29-20210212","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1097\/00005537-200312000-00014","article-title":"Immunohistochemical demonstration of vascular endothelial growth factor in vestibular schwannomas correlates to tumor growth rate.","volume":"113","author":"Caye-Thomasen","year":"2003","journal-title":"Laryngoscope"},{"key":"R17-29-20210212","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1080\/00016480310005101","article-title":"Expression of angiogenic growth factors in acoustic neurinoma.","volume":"123","author":"Brieger","year":"2003","journal-title":"Acta Otolaryngol"},{"key":"R19-29-20210212","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1634\/theoncologist.8-6-531","article-title":"Activation of tyrosine kinases in cancer.","volume":"8","author":"Vlahovic","year":"2003","journal-title":"Oncologist"},{"key":"R20-29-20210212","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/35077225","article-title":"Oncogenic kinase signalling.","volume":"411","author":"Blume-Jensen","year":"2001","journal-title":"Nature"},{"key":"R21-29-20210212","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1126\/science.7892601","article-title":"Tyrosine kinase inhibition: an approach to drug development.","volume":"267","author":"Levitzki","year":"1995","journal-title":"Science"},{"key":"R22-29-20210212","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1158\/1078-0432.CCR-0754-03","article-title":"Imatinib mesylate (Gleevec) inhibits ovarian cancer cell growth through a mechanism dependent on platelet-derived growth factor receptor alpha and Akt inactivation.","volume":"10","author":"Matei","year":"2004","journal-title":"Clin Cancer Res"},{"key":"R23-29-20210212","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1038\/sj.onc.1203698","article-title":"Growth inhibition and modulation of kinase pathways of small cell lung cancer cell lines by the novel tyrosine kinase inhibitor STI 571.","volume":"19","author":"Wang","year":"2000","journal-title":"Oncogene"},{"key":"R24-29-20210212","first-page":"3319","article-title":"The selective tyrosine kinase inhibitor STI571 inhibits small cell lung cancer growth.","volume":"6","author":"Krystal","year":"2000","journal-title":"Clin Cancer Res"},{"key":"R25-29-20210212","first-page":"5143","article-title":"Intracranial inhibition of platelet-derived growth factor-mediated glioblastoma cell growth by an orally active kinase inhibitor of the 2-phenylaminopyrimidine class.","volume":"60","author":"Kilic","year":"2000","journal-title":"Cancer Res"},{"key":"R26-29-20210212","doi-asserted-by":"crossref","first-page":"5054","DOI":"10.1038\/sj.onc.1204704","article-title":"STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: biological and clinical implications.","volume":"20","author":"Tuveson","year":"2001","journal-title":"Oncogene"},{"key":"R27-29-20210212","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0093-7754(01)90100-9","article-title":"Platelet-derived growth factor receptors: a therapeutic target in solid tumors.","volume":"28","author":"George","year":"2001","journal-title":"Semin Oncol"},{"key":"R28-29-20210212","first-page":"475","article-title":"Establishment and characterization of a schwannoma cell line from a patient with neurofibromatosis 2.","volume":"20","author":"Hung","year":"2002","journal-title":"Int J Oncol"},{"key":"R29-29-20210212","first-page":"1811","article-title":"Expression of the hst-1 and c-kit protooncogenes in human testicular germ cell tumors.","volume":"51","author":"Strohmeyer","year":"1991","journal-title":"Cancer Res"},{"key":"R30-29-20210212","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s004410050859","article-title":"Ultrastructural identification of the c-kit-expressing interstitial cells in the rat stomach: a comparison of control and Ws\/Ws mutant rats.","volume":"289","author":"Ishikawa","year":"1997","journal-title":"Cell Tissue Res"},{"key":"R31-29-20210212","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0304-3835(00)00387-6","article-title":"Expression of the c-kit protein is associated with certain subtypes of salivary gland carcinoma.","volume":"154","author":"Jeng","year":"2000","journal-title":"Cancer Lett"},{"key":"R32-29-20210212","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1309\/BTLN5WTMJ3PCNRRC","article-title":"Expression of protein tyrosine kinases in head and neck squamous cell carcinomas.","volume":"124","author":"Ongkeko","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"R33-29-20210212","first-page":"2416","article-title":"Preferential expression of c-kit protooncogene transcripts in small cell lung cancer.","volume":"51","author":"Sekido","year":"1991","journal-title":"Cancer Res"},{"key":"R34-29-20210212","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/jnr.490370314","article-title":"Role for the stem cell factor\/KIT complex in Schwann cell neoplasia and mast cell proliferation associated with neurofibromatosis.","volume":"37","author":"Ryan","year":"1994","journal-title":"J Neurosci Res"},{"key":"R35-29-20210212","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/sj.onc.1201978","article-title":"Expression of Kit in neurofibromin-deficient human Schwann cells: role in Schwann cell hyperplasia associated with type 1 neurofibromatosis.","volume":"17","author":"Badache","year":"1998","journal-title":"Oncogene"},{"key":"R36-29-20210212","first-page":"431","article-title":"Expression in lung carcinomas of platelet-derived growth factor and its receptors.","volume":"77","author":"Kawai","year":"1997","journal-title":"Lab Invest"},{"key":"R37-29-20210212","first-page":"4550","article-title":"Expression and prognostic significance of platelet-derived growth factor and its receptors in epithelial ovarian neoplasms.","volume":"53","author":"Henriksen","year":"1993","journal-title":"Cancer Res"},{"key":"R38-29-20210212","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1146\/annurev.pharmtox.45.120403.100124","article-title":"Tyrosine kinase inhibitors and the dawn of molecular cancer therapeutics.","volume":"45","author":"Tibes","year":"2005","journal-title":"Annu Rev Pharmacol Toxicol"}],"container-title":["Otology &amp; Neurotology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MAO.0b013e3182009665","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:48:30Z","timestamp":1620960510000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00129492-201101000-00029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/mao.0b013e3182009665","relation":{},"ISSN":["1531-7129"],"issn-type":[{"value":"1531-7129","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}